Abstract

This is a Phase I program to study the effectiveness of ethyletiopurpurin (SnET2) and octaethylbenzochlorin iminium salt (BCIS1) photosynthesizers and photodynamic therapy (PDT) in the treatment of refractory glaucoma. During the program, the uptake of the photosynthesizers in the ciliary body and surrounding tissue will be measured. In addition, PDT using wavelengths near 665nm and 800nm will be studied for its cyclodestruction effect.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43EY011034-01
Application #
2165279
Study Section
Special Emphasis Panel (ZRG7-SSS-1 (17))
Project Start
1995-07-26
Project End
1996-01-25
Budget Start
1995-07-26
Budget End
1996-01-25
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost

  Institution

Name
Pdt Systems
Department
Type
DUNS #
City
Santa Barbara
State
CA
Country
United States
Zip Code
93117